Page last updated: 2024-08-24

1,2-distearoyllecithin and Leukemia P388

1,2-distearoyllecithin has been researched along with Leukemia P388 in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bally, MB; Choi, L; Cullis, PR; de Jong, G; Longman, SA1
Krishna, R; Mayer, LD1

Other Studies

2 other study(ies) available for 1,2-distearoyllecithin and Leukemia P388

ArticleYear
A two-step targeting approach for delivery of doxorubicin-loaded liposomes to tumour cells in vivo.
    Cancer chemotherapy and pharmacology, 1995, Volume: 36, Issue:2

    Topics: Animals; Bacterial Proteins; Doxorubicin; Drug Carriers; Female; Flow Cytometry; Leukemia P388; Liposomes; Metabolic Clearance Rate; Mice; Mice, Inbred Strains; Microscopy, Fluorescence; Peritoneal Lavage; Phosphatidylcholines; Streptavidin

1995
Liposomal doxorubicin circumvents PSC 833-free drug interactions, resulting in effective therapy of multidrug-resistant solid tumors.
    Cancer research, 1997, Dec-01, Volume: 57, Issue:23

    Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cholesterol; Cyclosporins; Doxorubicin; Drug Carriers; Drug Resistance, Multiple; Female; Leukemia P388; Liposomes; Metabolic Clearance Rate; Mice; Phosphatidylcholines; Tissue Distribution

1997